Clairo

Project Manager

Costa Rica

Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Clinical ResearchIndustries

Requirements

Candidates should possess a Bachelor's degree and/or proven project management skills or industry experience, with 1-4 years in pharmaceutical project management or related fields. A Clario PM Certification is required as applicable, along with knowledge of the drug development process. Essential skills include excellent organizational, interpersonal, time management, and prioritization abilities, as well as strong verbal and written communication in English. Proficiency in Microsoft Office products, attention to detail, and responsiveness are necessary. A valid passport and willingness to travel approximately 20% are also required.

Responsibilities

The Project Manager will lead eCOA projects for StudyWorks, directing and managing services to ensure high quality, on-time, and on-budget delivery while promoting excellent customer service. This includes managing study planning, setup, monitoring, and closeout phases, gathering customer requirements, developing study documentation, distributing and tracking equipment, creating reports, and archiving data. The role involves monitoring study timelines, managing financial components like budget reviews and revenue forecasting, identifying and mitigating study risks, and handling negotiations. Responsibilities also include resolving customer issues, ensuring compliance with training, presenting study services at meetings, and assisting with training new project management team members.

Skills

Project Management
eCOA
Study Management
Customer Requirements Gathering
Study Documentation
Budget Management
Risk Management
Negotiation
Problem Solving
Client Meetings
Team Collaboration

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI